Our partners
The Gene Therapy Innovation and Manufacturing Centre (GTIMC) brings together partners from the North of England, the Midlands and Wales.
The Gene Therapy Innovation and Manufacturing Centre (GTIMC) has been formed as part of the Innovation Hubs for Gene Therapies. The Innovation Hubs for Gene Therapies include ourselves, the GTIMC in Sheffield, the Gene Therapy Vector Facility at King's College London, Royal Free, UCL Gene Therapy Hub (London hub) and Clinical Biotechnology Centre at NHS Blood and Transplant, Filton (Bristol hub).
Our partners include:
- Cell & Gene Therapy Catapult
- Centre of Process Innovation (CPI)
- University of Birmingham
- University of Liverpool
- The Midlands-Wales Advanced Therapies Treatment Centre [MW-ATTC]
- University of Leeds
- University of Leicester
- University of York
- Cardiff University
- iMatch
- University of Bradford
- Northern Health Science Alliance (NHSA)
- NHS Hospital Trusts of Sheffield, Leeds, Birmingham Women’s and Children Hospital
- Leeds Teaching Hospitals NHS Foundation Trust
- Genomic Laboratory Hubs
- Lonza AG
- Advanced Manufacturing Research Centre (AMRC)
- National Horizons Centre (NHC)
- National Institute for Biological Standards
- South Yorkshire Mayoral Combined Authority
- Sheffield Children Hospital
- University College London
- University of Cambridge
The GTIMC will align with the new Accelerating Research & Development for Advanced Therapies (ARDAT) consortium to enhance global regulatory harmonisation, biobanking and safety of advanced therapies.
Partner with us
We are proud to work in collaboration with a number of charities, global institutes and leading global organisations and seek new and exciting opportunities to further enhance our translational research.
By working together we believe we can find novel solutions to the biggest rare disease challenges and help to change lives.
To work with us contact Prof. Mimoun Azzouz
